Schroeder Thilo's Form 4 filing
PMV Pharmaceuticals, Inc. (PMVP) · filed Oct 4, 2021
- Accession no.
- 0001209191-21-059163
- Filed
- Oct 4, 2021
- Trade date
- Sep 30-Oct 4, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $439.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2021 | Common Stock | SSaleDisposed | −2,978 | $30.03 | −$89,429.34 | 1,113,724 | Indirect | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −11,541 | $30.10 | −$347,384.1 | 1,102,183 | Indirect | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −100 | $30.08 | −$3,008 | 1,102,083 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.